Indian Council of Medical Research and Indian Immunologicals Advance Indigenous Kyasanur Forest Disease Vaccine into Phase I Trials
Key Highlights: Implications: IIL grabs first-mover advantage in...
Breaking developments shaping Indian pharma, biotech, and healthcare.
Fast, factual reporting on what just happened.
Updated continuously, without the clutter.
Key Highlights: Implications: IIL grabs first-mover advantage in...
Key Highlights: Implications: This partnership accelerates peptide...
Key Highlights: Implications: Durvalumab storms earlier...
Key Highlights: Implications: Sun ignites generics price war...
Key Highlights: Implications: India’s pet care market reaches...
Key Highlights: Implications: Tishtha detonates pricing bombs on...
Key Highlights: Implications: Quality failures erode trust in...
Key Highlights: Implications: Jubilant catapults into top-tier...
Key Highlights: Implications: The appointment...
Key Highlights: Implications: Lantern’s Bengaluru expansion...